IBRI is dedicated to advancing science that contributes directly to the improvement of human health. We create not only knowledge, but the tools, technology, and talent to turn new scientific discoveries into breakthrough treatments for serious diseases.
About Us
A mission to make a difference in people’s lives
Alan Palkowitz, PhD
President, Chief Executive Officer, and Chief Scientific Officer
D. Wade Clapp, MD
Strategic Advisor in Pediatric Oncology
Christina Bodurow, PhD
Chief Operating Officer
Christopher Conway, JD
Chief Philanthropy, Communications, and Strategic Partnerships Officer
Patrick Knerr, PhD
Vice President, Metabolic Translational Research and Peptide Innovation
Will Lawson, JD
Chief Legal and Administrative Officer
Timothy Richardson, PhD
Vice President, Alzheimer's Disease and Related Dementias
Michele Sawyer, CPA
Executive Vice President and Chief Financial Officer
Louis Stancato, PhD
Vice President of Enabling Technologies and Global Leader of Pediatric Rare Disease Platform
Derek Turner, MBA
Vice President of Finance
Nansa Amarsaikhan, PhD
Staff Scientist I
Jonathan Crawford, PhD
Staff Scientist I
Elizabeth Delery, PhD
Staff Scientist II
Jonathan Douros, PhD
Senior Scientific Director
Mike East, PhD
Staff Scientist II
Francis O. Enane, PhD
Staff Scientist III
Bryan Ferrick, PhD
Postdoctoral Fellow
Anna Geisinger
Researcher III
Joe Jakubowski, PhD
Senior Scientific Director
June Javens-Wolfe, PhD
Researcher IV
Travis S. Johnson, PhD
Scientific Director
Mike Kalwat, PhD
Staff Scientist III
Supreet Kaur, PhD
Postdoctoral Research Scientist
Peter Lander, PhD
Senior Scientific Director
Olivia Lazaro
Researcher I, Biostatistics
Emma K. Lendy, PhD
Scientific Director
Sydney Leohr
Researcher I
Tanasha Lertjanyarak
Researcher II
Hope Liechty
Researcher II
Betty Lorentz
Researcher I
Daisy Magallanes-Robles
Researcher II
Connor A. Mahler
Researcher II
Roberto Mallone, MD, PhD
Senior Scientific Director
Mustapha Moussaif, PhD
Staff Scientist III
Stephanie Mowery, PhD
Senior Scientific Director
Andrea Ordonez
Researcher I
Luna Park
Researcher I
Deep Patel, PharmD
Researcher II
Mariya Raleigh
Researcher II
Sylvia Robertson
Researcher II
Michael Robo, PhD
Staff Scientist II
Jarrid M. Ronnebaum, PhD
Scientist
Gitanjali Roy
Researcher II
Tom Ryder
Researcher II
Mackenzie M. Spicer Rysted, PhD
Postdoctoral Fellow
Lilia (Lily) Sanchez, PhD
Postdoctoral Fellow
Rashmi Shrinivasan
Researcher II
Jake Smiley
Researcher I
Keith Stayrook
Staff Scientist III, Neuropharmacology
Abdul Qadir Syed, PhD
Scientific Director
Matthew Valli
Staff Scientist III
Kazuhiro Yamada, PhD
Staff Scientist II
Sylvaine You, PhD
Senior Scientific Director
Allison Ambrosia-Brown
Senior Associate, Strategic Partnerships
Sydney Burdo
Human Resources Generalist
Danielle Conlon Contreras
Senior Director, Philanthropy
Lisa Davis, MBA
Senior Director, Strategic Partnerships
Becky Klein, PhD
Scientific Director, Project Management
Gajanan C. Kulkarni, PhD
Associate, Laboratory Operations & EHS
Josephina Latuszek, JD
Senior Business Integrator and Data Manager
Grace Patel, RD
Senior Associate, Strategic Communications
Becky Reynolds
Director, Research Grants Administration
Kobe Rogers
Director
Beth Slusser
Senior Director, Human Resources
Daniel Evans, Jr.
Former Chief Executive Officer, Indiana University Health
Tatiana Foroud, PhD
Executive Associate Dean for Research Affairs, Indiana University School of Medicine
Michael Harrington
Former Senior Vice President and General Counsel, Eli Lilly and Company
Lisa Hershman
Indiana Secretary of Management and Budget
Jay Hess, MD, PhD, MHSA
Executive Vice President for University Clinical Affairs, Indiana University
David Ingram, MD
Chief Medical Executive and Executive Vice President, Indiana University Health
John Lechleiter, PhD
Former Chairman, President, and Chief Executive Officer, Eli Lilly and Company
Debra Luffer-Atlas, PhD
Senior Vice President of Research, Eli Lilly and Company
Russell J. Mumper
Vice President for Research, Indiana University
Alan D. Palkowitz, PhD
President and CEO, IBRI
Dan Peterson
Vice President, Industry and Government Affairs, Cook Group Inc.
Jeffrey F. Rhoads, PhD
Vice President for Research, University of Notre Dame
Preeti Sivasankar, PhD
Vice President for Research Innovation, Purdue University
Aaron Schacht
Chief Executive Officer, BiomEdit, LLC
Wendy Srnic, PhD
Vice President of Biotechnology, Corteva Agriscience
Kaye Vitug
Senior Vice President and Chief Financial Officer, Roche Diagnostics North America
Vince Wong
President and CEO, BioCrossroads
Founders
Discover how a bold idea helped shape IBRI’s founding. Recognizing Indianapolis’ life sciences strengths—and the need for stronger connections between academia and industry—our founders created a unique model to help turn promising science into real-world therapies, technologies, and impact.
Watch video
Our rich innovation ecosystem
Located in the BioHeartland Corridor, IBRI is at a nexus of top research universities and hospitals, entrepreneurial biotechnology startups, and premier pharmaceutical companies.
Through cross-sector collaboration with organizations such as the Indiana University School of Medicine, Indiana University, Purdue University, IU Health, and Eli Lilly and Company, we advance science, generate economic growth, create high-value jobs, and foster a new generation of biotech pioneers.
